These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


191 related items for PubMed ID: 7431109

  • 21. 99mTc-labelled compounds prepared with antimony(III) as reducing agent.
    Vilcek S, Machán V, Kalincák M.
    Radiobiol Radiother (Berl); 1983; 24(1):103-8. PubMed ID: 6407061
    [No Abstract] [Full Text] [Related]

  • 22. Synthesis, characterization, and biological evaluation of technetium(III) complexes with tridentate/bidentate S,E,S/P,S coordination (E = O, N(CH(3)), S): a novel approach to robust technetium chelates suitable for linking the metal to biomolecules.
    Pietzsch HJ, Seifert S, Syhre R, Tisato F, Refosco F, Leibnitz P, Spies H.
    Bioconjug Chem; 2003; 14(1):136-43. PubMed ID: 12526702
    [Abstract] [Full Text] [Related]

  • 23. Effect of oxygen on the reduction of pertechnetate by stannous ion.
    Owunwanne A, Church LB, Blau M.
    J Nucl Med; 1977 Aug; 18(8):822-6. PubMed ID: 874171
    [Abstract] [Full Text] [Related]

  • 24. Charge and nature of technetium species produced in the reduction of pertechnetate by stannous ion.
    Owunwanne A, Marinsky J, Blau M.
    J Nucl Med; 1977 Nov; 18(11):1099-105. PubMed ID: 915087
    [Abstract] [Full Text] [Related]

  • 25. The lanthanum precipitation method. Part 2: quantification of the conditional interaction constant between technetium(IV) and humic substances.
    Geraedts K, Maes A.
    Chemosphere; 2008 Sep; 73(4):491-7. PubMed ID: 18706673
    [Abstract] [Full Text] [Related]

  • 26. 99mTc-labelled compounds prepared with molybdenum III as reducing agent.
    Vilcek S, Machán V, Kalincák M.
    Int J Appl Radiat Isot; 1984 Mar; 35(3):228-30. PubMed ID: 6425226
    [Abstract] [Full Text] [Related]

  • 27. Technical problems associated with the production of technetium Tc 99m tin(II) pyrophosphate kits.
    Kowalsky RJ, Dalton DR.
    Am J Hosp Pharm; 1981 Nov; 38(11):1722-6. PubMed ID: 7304626
    [Abstract] [Full Text] [Related]

  • 28. Speciation of technetium(IV) in bicarbonate media.
    Alliot I, Alliot C, Vitorge P, Fattahi M.
    Environ Sci Technol; 2009 Dec 15; 43(24):9174-82. PubMed ID: 20000508
    [Abstract] [Full Text] [Related]

  • 29. Ligand exchange upon oxidation of a dinuclear Mn complex--detection of structural changes by FT-IR spectroscopy and ESI-MS.
    Eilers G, Zettersten C, Nyholm L, Hammarström L, Lomoth R.
    Dalton Trans; 2005 Mar 21; (6):1033-41. PubMed ID: 15739005
    [Abstract] [Full Text] [Related]

  • 30. A simple "electrolytic" preparation of a 99mTc(Sn)-citrate renal scanning agent.
    Schneider PB.
    J Nucl Med; 1973 Nov 21; 14(11):843-5. PubMed ID: 4743043
    [No Abstract] [Full Text] [Related]

  • 31. Technetium reduction in sediments of a shallow aquifer exhibiting dissimilatory iron reduction potential.
    Wildung RE, Li SW, Murray CJ, Krupka KM, Xie Y, Hess NJ, Roden EE.
    FEMS Microbiol Ecol; 2004 Jul 01; 49(1):151-62. PubMed ID: 19712393
    [Abstract] [Full Text] [Related]

  • 32. Evaluation of formamidine sulfinic acid and other reducing agents for use in the preparation of Tc-99m labeled radiopharmaceuticals.
    Fritzberg AR, Lyster DM, Dolphin DH.
    J Nucl Med; 1977 Jun 01; 18(6):553-7. PubMed ID: 192859
    [Abstract] [Full Text] [Related]

  • 33. Dissolution of technetium(IV) oxide by natural and synthetic organic ligands under both reducing and oxidizing conditions.
    Gu B, Dong W, Liang L, Wall NA.
    Environ Sci Technol; 2011 Jun 01; 45(11):4771-7. PubMed ID: 21539349
    [Abstract] [Full Text] [Related]

  • 34. Mixed-ligand technetium(III) complexes with tetradendate/monodendate NS(3)/isocyanide coordination: a new nonpolar technetium chelate system for the design of neutral and lipophilic complexes stable in vivo.
    Pietzsch HJ, Gupta A, Syhre R, Leibnitz P, Spies H.
    Bioconjug Chem; 2001 Jun 01; 12(4):538-44. PubMed ID: 11459458
    [Abstract] [Full Text] [Related]

  • 35. A survey of reducing agents for the synthesis of tetraphenylarsonium oxotechnetiumbis(ethanedithiolate) from [99Tc] pertechnetate in aqueous solution.
    Jones AG, Orvig C, Trop HS, Davison A, Davis MA.
    J Nucl Med; 1980 Mar 01; 21(3):279-81. PubMed ID: 7365521
    [Abstract] [Full Text] [Related]

  • 36. Fe(III) photocatalytic reduction of Cr(VI) by low-molecular-weight organic acids with alpha-OH.
    Sun J, Mao JD, Gong H, Lan Y.
    J Hazard Mater; 2009 Sep 15; 168(2-3):1569-74. PubMed ID: 19372002
    [Abstract] [Full Text] [Related]

  • 37. The chemical state of 99m Tc in biomedical products. II. The chelation of reduced technetium with DTPA.
    Eckelman WC, Meinken G, Richards P.
    J Nucl Med; 1972 Aug 15; 13(8):577-81. PubMed ID: 5041632
    [No Abstract] [Full Text] [Related]

  • 38. Electrolytic complexing of glucoheptonate and technetium-99m.
    Chi SL, Hoag SG, Yanchick VA.
    J Nucl Med; 1978 May 15; 19(5):520-4. PubMed ID: 641575
    [Abstract] [Full Text] [Related]

  • 39. Use of Fe(II) or Sn(II) alone for technetium labeling of albumin.
    Lin MS, Winchell HS, Shipley BA.
    J Nucl Med; 1971 May 15; 12(5):204-11. PubMed ID: 5580834
    [No Abstract] [Full Text] [Related]

  • 40. Tetranuclear copper(II) complexes bridged by alpha-D-glucose-1-phosphate and incorporation of sugar acids through the Cu4 core structural changes.
    Kato M, Sah AK, Tanase T, Mikuriya M.
    Inorg Chem; 2006 Aug 21; 45(17):6646-60. PubMed ID: 16903719
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.